Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Zuclopenthixol:

Zuclopenthixol dihydrochloride for schizophrenia. Bryan EJ et al. Cochrane Database Syst Rev. (2017)

Zuclopenthixol versus placebo for schizophrenia. Lacey M et al. Cochrane Database Syst Rev. (2015)

Use of zuclopenthixol in the treatment of aggression in Huntington's disease. Tibrewal P et al. Asian J Psychiatr. (2017)

Search results

Items: 1 to 20 of 550

1.

A Compilation of Serum Concentrations of 12 Antipsychotic Drugs in a Therapeutic Drug Monitoring Setting.

Jönsson AK, Spigset O, Reis M.

Ther Drug Monit. 2019 Jun;41(3):348-356. doi: 10.1097/FTD.0000000000000585.

PMID:
31025986
2.

Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?

Osimo EF, Goujon MJ, Perez J, Murray GK.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e228573. doi: 10.1136/bcr-2018-228573.

PMID:
30936353
3.

Commercial Pharmacogenetic Tests in Psychiatry: Do they Facilitate the Implementation of Pharmacogenetic Dosing Guidelines?

Fan M, Bousman CA.

Pharmacopsychiatry. 2019 Mar 21. doi: 10.1055/a-0863-4692. [Epub ahead of print]

PMID:
30900236
4.

11 Therapeutic Equivalences in Long-term Antipsychotics.

Gómez Sánchez-Lafuente C.

CNS Spectr. 2019 Feb;24(1):178-179. doi: 10.1017/S1092852919000075.

PMID:
30859942
5.

Electroencephalography identifies encephalopathy associated with adjunctive lithium and zuclopenthixol.

Herath U, Thomas N, Krishna A, Pantelis C.

Aust N Z J Psychiatry. 2019 Jan 17:4867418823277. doi: 10.1177/0004867418823277. [Epub ahead of print] No abstract available.

PMID:
30654623
6.

Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus: A Systematic Review.

Uguz F.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):162-167. doi: 10.1097/JCP.0000000000001002.

PMID:
30624301
7.

A Case of Hyper Sexuality Probably Associated with Clozapine.

Thomson SR, Patil N, Ommurugan B, Bhandary RK.

Psychopharmacol Bull. 2018 Jun 20;48(4):20-24.

PMID:
30618473
8.
9.

Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report.

Mirza H, Harding D, Al-Balushi N.

Sultan Qaboos Univ Med J. 2018 May;18(2):e208-e210. doi: 10.18295/squmj.2018.18.02.014. Epub 2018 Sep 9.

10.

Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose.

Korchia T, Blackman G, Cermolacce M, Richieri R.

BMJ Case Rep. 2018 Aug 3;2018. pii: bcr-2017-223922. doi: 10.1136/bcr-2017-223922.

11.

Abnormal serum potassium levels and 6-month all-cause mortality in patients co-treated with antipsychotic and diuretic drugs - A Danish register-based cohort study.

Marcussen M, Polcwiartek C, Mills EHA, Jirback F, Bylin P, Torp-Pedersen C, Søgaard P, Kragholm K.

Eur Neuropsychopharmacol. 2018 Sep;28(9):1006-1014. doi: 10.1016/j.euroneuro.2018.06.008. Epub 2018 Jul 17.

PMID:
30017260
12.

Zuclopenthixol.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

13.

Tizanidine is not effective treating EPMS.

Niederhofer H.

Med Hypotheses. 2018 Jul;116:147. doi: 10.1016/j.mehy.2018.05.007. Epub 2018 May 19. No abstract available.

PMID:
29857901
14.

Simultaneous Determination of Antipsychotic Drugs and Their Active Metabolites by LC-MS-MS and its Application to Therapeutic Drug Monitoring.

Miroshnichenko II, Baymeeva NV.

J Chromatogr Sci. 2018 Jul 1;56(6):510-517. doi: 10.1093/chromsci/bmy024.

PMID:
29635397
15.

Zuclopenthixol dihydrochloride for schizophrenia.

Bryan EJ, Purcell MA, Kumar A.

Cochrane Database Syst Rev. 2017 Nov 16;11:CD005474. doi: 10.1002/14651858.CD005474.pub2. Review.

16.

Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.

Khan Q, Ismail M, Haider I, Khan F.

Int J Clin Pharm. 2017 Dec;39(6):1256-1264. doi: 10.1007/s11096-017-0532-5. Epub 2017 Sep 12.

PMID:
28895028
17.

Interest of Single Hair Analysis to Document Drug Exposure: Literature Review and a Case Report Involving Zuclopenthixol.

Allibe N, Kintz P, Faure A, Paysant F, Michard-Lenoir AP, Stanke-Labesque F, Scolan V, Eysseric-Guerin H.

Curr Pharm Des. 2017;23(36):5502-5510. doi: 10.2174/1381612823666170622100443.

PMID:
28641534
18.

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.

Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H.

JAMA Psychiatry. 2017 Jul 1;74(7):686-693. doi: 10.1001/jamapsychiatry.2017.1322.

19.

Use of zuclopenthixol in the treatment of aggression in Huntington's disease.

Tibrewal P, Bastiampillai T, Dhillon R, Cheng R, Fonseka HT.

Asian J Psychiatr. 2017 Apr;26:152-153. doi: 10.1016/j.ajp.2017.01.011. Epub 2017 Jan 19. No abstract available.

PMID:
28483083
20.

Polypharmacological in Silico Bioactivity Profiling and Experimental Validation Uncovers Sedative-Hypnotic Effects of Approved and Experimental Drugs in Rat.

Drakakis G, Wafford KA, Brewerton SC, Bodkin MJ, Evans DA, Bender A.

ACS Chem Biol. 2017 Jun 16;12(6):1593-1602. doi: 10.1021/acschembio.7b00209. Epub 2017 May 1.

PMID:
28414209

Supplemental Content

Loading ...
Support Center